3 completed, 2 terminated. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Terminated 2 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Recurrent Malignant Peripheral Nerve Sheath Tumor: new trials by email Literature Review of Recurrent Malignant Peripheral Nerve Sheath Tumor trials Research Report on Recurrent Malignant Peripheral Nerve Sheath Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults Allogeneic Hematopoietic Stem Cell Transplantation, Cyclosporine, Etoposide - Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Phase 2 | Terminated | M.D. Anderson Cancer Center | 1 | 2020-08-19 | 2025-06-29 |
| Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery Computed Tomography, Laboratory Biomarker Analysis, Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter - Metastatic Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1 | Phase 1 | Completed | Mayo Clinic | 9 | 2017-03-22 | 2024-09-27 |
| Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma Pazopanib, Pazopanib Hydrochloride, Sapanisertib - High Grade Sarcoma, Metastatic Leiomyosarcoma | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 151 | 2015-11-30 | 2022-08-23 |
| Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma Laboratory Biomarker Analysis, Lorvotuzumab Mertansine, Pharmacological Study - Pleuropulmonary Blastoma, Recurrent Malignant Peripheral Nerve Sheath Tumor | Phase 2 | Completed | Children's Oncology Group | 62 | 2015-10-12 | 2022-01-13 |
| Alisertib in Treating Patients With Advanced or Metastatic Sarcoma Alisertib, Laboratory Biomarker Analysis - Myxofibrosarcoma, Recurrent Adult Soft Tissue Sarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 72 | 2012-08-22 | 2017-11-30 |
Neurofibrosarcoma (5) · Dermatofibrosarcoma (2) · Histiocytoma, Malignant Fibrous (2) · Leiomyosarcoma (2) · Neuroblastoma (2) · Rhabdomyosarcoma (2) · Sarcoma, Synovial (2) · Desmoplastic Small Round Cell Tumor (1) · Liposarcoma (1) · Neuroectodermal Tumors, Primitive, Peripheral (1) · Neurofibromatosis 1 (1) · Pleuropulmonary blastoma (1) · Sarcoma (1) · Wilms Tumor (1)
Fibrosarcoma (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms, Connective Tissue (5) · Neoplasms, Connective and Soft Tissue (5) · Neoplasms, Fibrous Tissue (5) · Neoplasms, Nerve Tissue (5) · Nerve Sheath Neoplasms (5) · Nervous System Diseases (5) · Nervous System Neoplasms (5) · Neurofibroma (5) · Neuromuscular Diseases (5) · Peripheral Nervous System Diseases (5) · Peripheral Nervous System Neoplasms (5) · Neoplasms, Muscle Tissue (4)
Ado-Trastuzumab Emtansine (1) · Antilymphocyte Serum (1) · Biopsy (1) · Cyclosporine (1) · Cyclosporins (1) · Etoposide (1) · High-Energy Shock Waves (1) · MLN 8237 (1) · Magnetic Resonance Spectroscopy (1) · Melphalan (1) · Mycophenolic Acid (1) · Photons (1) · Specimen Handling (1) · Stem Cell Transplantation (1) · Tacrolimus (1)
National Cancer Institute (NCI) (2) · Children's Oncology Group (1) · M.D. Anderson Cancer Center (1) · Mayo Clinic (1)
United States (5)
Dusica Babovic-Vuksanovic, MD (1) · James I Geller (1) · Jeremy S Connors, MD (1) · Mark Dickson (1) · William D Tap (1)
U10CA180821 (2), U10CA031946 (1), U10CA180886 (1)